PPARG and Myocardial fibrosis: During cardiovascular diseases, the activation of PPARγ reduces myocardial fibrosis [36] and apoptosis [37], improves myocardial ischemia-reperfusion injury [38], and inhibits myocardial hypertrophy [39].